The use of a telematic connection for the follow-up of hypertensive patients improves the cardiovascular prognosis

Journal of Hypertension

Volumn 23, Issue 7, 2005, Pages 1417-1423

  De Luca, Nicola ^a   Izzo, Raffaele ^a   Iaccarino, Guido ^a   Malini, Pier Luigi ^b   Morisco, Carmine ^a   Rozza, Francesco ^a   Iovino, Gianni Luigi ^a   Rao, Maria Assunta Elena ^a   Bodenizza, Clara ^a   Lanni, Francesca ^a   Guerrera, Luigi ^a   Arcucci, Oreste ^c   Trimarco, Bruno ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c IRCCS NEUROMED   (Italy)

Author keywords

Hospitalization; Hypertension; Telemedicine; Therapy

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE; TELECOMMUNICATION;

EID: 21644444545     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000173526.65555.55     Document Type: Article

References (14)

1. Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology. Circulation 2000; 101:329-335.
2. Kjeldsen SE, Farsang C, Sleigh P, Mancia G. World Health Organization, International Society of Hypertension. 1999 WHO/ISH hypertension guidelines -highlights and ESH update. J Hypertens 2001; 19:2285-2288.
3. Whitworth JA, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21:1983-1992.
4. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
5. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43:10-17.
6. Abdoh AA, Krousel-Wood MA, Re RN. Accuracy of telemedicine in detecting uncontrolled hypertension and its impact on patient management. Telemed J E Health 2003; 9:315-323.
7. Moller DS, Dideriksen A, Sorensen S, Madsen LD, Pedersen EB. Accuracy of telemedical home blood pressure measurement in the diagnosis of hypertension. J Hum Hypertens 2003; 17:549-554.
8. Rogers MA, Buchan DA, Small D, Stewart CM, Krenzer BE. Telemedicine improves diagnosis of essential hypertension compared with usual care. J Telemed Telecare 2002; 8:344-349.
9. Izzo R, Trotta R, Iovino GL, Rozza F, Grasso E, Brancati C, et al. A new approach to improve effectiveness of antihypertensive treatment. Am J Hypertens 2001; 14:232 (abstract).
10. Motulsky H. Intuitive biostatistics. Oxford: Oxford University Press; 1995.
11. Lembo G, De Luca N, Battagli C, Iovino G, Aretini A, Musicco M, et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 2001; 32:735-740.
12. Trimarco B, Ricciardelli B, De Luca N, De Simone A, Cuocolo A, Galva MD, et al. Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents. Circulation 1985; 72:38-46.
13. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al., VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363:2022-2031.
14. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al., LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359:995-1003.